Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Polomar Health Services (PMHS) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for Polomar Health Services (PMHS) over the last 4 years, with Q3 2025 value amounting to $28.0 million.

  • Polomar Health Services' Shares Outstanding (Weighted Average) rose 127.51% to $28.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year increase of 127.51%. This contributed to the annual value of $27.7 million for FY2024, which is 590.97% up from last year.
  • Per Polomar Health Services' latest filing, its Shares Outstanding (Weighted Average) stood at $28.0 million for Q3 2025, which was up 127.51% from $27.7 million recorded in Q2 2025.
  • Over the past 5 years, Polomar Health Services' Shares Outstanding (Weighted Average) peaked at $452.5 million during Q4 2022, and registered a low of $292430.0 during Q3 2022.
  • Moreover, its 4-year median value for Shares Outstanding (Weighted Average) was $27.7 million (2024), whereas its average is $70.6 million.
  • Examining YoY changes over the last 5 years, Polomar Health Services' Shares Outstanding (Weighted Average) showed a top increase of 935715.56% in 2023 and a maximum decrease of 9422.97% in 2023.
  • Over the past 4 years, Polomar Health Services' Shares Outstanding (Weighted Average) (Quarter) stood at $452.5 million in 2022, then crashed by 94.23% to $26.1 million in 2023, then increased by 5.91% to $27.7 million in 2024, then rose by 1.27% to $28.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $28.0 million for Q3 2025, versus $27.7 million for Q2 2025 and $27.7 million for Q1 2025.